Johnson, D. C., Corthals, S. L., Walker, B. A., Ross, F. M., Gregory, W. M., Dickens, N. J., . . . Morgan, G. J. (2011). Genetic factors underlying the risk of thalidomide-related neuropathy in patients with multiple myeloma. Journal of clinical oncology, 29(7), . https://doi.org/10.1200/JCO.2010.28.0792
Chicago-Zitierstil (17. Ausg.)Johnson, David C., et al. "Genetic Factors Underlying the Risk of Thalidomide-related Neuropathy in Patients with Multiple Myeloma." Journal of Clinical Oncology 29, no. 7 (2011). https://doi.org/10.1200/JCO.2010.28.0792.
MLA-Zitierstil (9. Ausg.)Johnson, David C., et al. "Genetic Factors Underlying the Risk of Thalidomide-related Neuropathy in Patients with Multiple Myeloma." Journal of Clinical Oncology, vol. 29, no. 7, 2011, https://doi.org/10.1200/JCO.2010.28.0792.